+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 1 Actively Recruiting clinical trials

E

Actively Recruiting

Upper limb impairments from neurological or traumatic injuries like stroke or brain injuries can reduce independence and quality of life. Increasing therapy dose may improve function and prevent decline, but limited therapist availability and costs make higher doses challenging. Robot-assisted therapy with minimal or no supervision could increase therapy dose with fewer resources. The ReHandyBot, developed at ETH Zurich, is an active rehabilitation device tested in stroke patients and now studied for feasibility and cost in clinical and ambulatory settings. ReHandyBot offers exercises for forearm and finger movements using virtual reality and haptic feedback, adapting exercise type and difficulty to each patient. Therapy session frequency and duration vary based on therapist instructions and patient needs. The study evaluates integrating ReHandyBot into routine rehabilitation, comparing supervised, minimally supervised, and unsupervised therapy. Patients admitted to clinics will be screened, receive trial sessions, and if appropriate, will have therapy sessions incorporated into their schedule, progressing from supervised to less supervised sessions as suitable. Participants will have data recorded on demographics, medical condition, therapy dose, and device use during their therapy. Questionnaires on usability and experience are completed after the final session. Researchers will monitor costs, therapy intensity, patient-to-therapist ratios, and feasibility of device use over approximately five years. Therapy dose increase and patient satisfaction are also assessed during clinic stays averaging four weeks.

Age: 18Years - 90YearsAll GendersPhase Not Applicable
2 locations